Globus Medical GMED recently launched the COHERE ALIF Spacer, the first Porous PEEK interbody spacer for anterior lumbar interbody fusion (ALIF) surgery. Additionally, the company introduced Modulus ...

Research analysts at Roth Capital lowered their Q1 2025 earnings estimates for Globus Medical in a research report issued to clients and investors on Thursday, March 13th. Roth Capital analyst J.

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) yesterday and set a price target of ...

StockNews.com lowered shares of Globus Medical (NYSE:GMED – Free Report) from a buy rating to a hold rating in a research ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Globus Medical (GMED – Research Report) and ...

Medtech company Globus Medical has expanded its spine portfolio by launching its Cohere anterior lumbar interbody fusion spacer and Modulus ALIF blades. The Cohere space is the first porous ...

AUDUBON, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology ...

Globus Medical, Inc. (NYSE: GMED) has unveiled two groundbreaking additions to its anterior lumbar interbody fusion (ALIF) ...

OsteoCentric Technologies has entered into a non-exclusive licensing agreement with Globus Medical.  OsteoCentric’s MIS Bone Preservation Tapping Technology & Instant Interlocking Thread-form is the ...

AUDUBON, Pa. - Globus Medical, Inc. (NYSE: GMED), a prominent musculoskeletal technology company with a market capitalization of $10.08 billion and impressive revenue growth of 60.62% in the last ...

Net income rose by 77% to $26.5 million, highlighting significant growth. Globus Medical's results underscore a strong quarter, with effective execution of strategic initiatives, notably the full ...